Delta‐Like‐1 Changes the Immunomodulatory Property of OP9 Cells
Lei Zhang(Institute of Hematology & Blood Diseases Hospital), Fang Nan-zhu(Yanbian University), Dian‐Chao Cui(Beijing Children’s Hospital), Ruijie Dang(Chinese PLA General Hospital), Ping Li(Capital Medical University), Tong Hao(Center for Interdisciplinary Studies), Yanmei Yang(Thomas Jefferson University), Xiaoxia Jiang(Hangzhou Women’s Hospital), Yanli Ni(Academy of Military Medical Sciences), Changyong Wang(Guilin Medical University)
Cited by 21
Related Papers
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Cloning and Functional Expression of the Human Histamine H<sub>3</sub>Receptor
|Molecular Pharmacology|1999|700
A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone
|Nature Protocols|2010|651
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H<sub>4</sub>) Expressed in Bone Marrow
|Molecular Pharmacology|2001|408